BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.16.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260506T170000
DTEND;TZID=Australia/Sydney:20260506T170000
DTSTAMP:20260620T090739
CREATED:20260303T024942Z
LAST-MODIFIED:20260303T024942Z
UID:10000265-1778086800-1778086800@melanoma.org.au
SUMMARY:NHMRC Ideas Grants
DESCRIPTION:The objective of the Ideas Grant scheme is to support innovative research projects addressing a specific question(s). \nThe expected outcomes are: \n\ninnovative and creative research\nfunding of researchers at all career stages\nfunding any area of health and medical research from discovery to implementation.\n\nIt is expected that the Chief Investigator A (CIA) will have the capability to lead the team in achieving the project aims. \nThe Ideas Grant scheme is not intended to support research where a clinical trial or cohort study is the primary objective. Applicants conducting projects which incorporate elements of clinical trial and/or cohort study must consider whether the project goals are more applicable to the Ideas Grant or Clinical Trials and Cohort Grant schemes. \nIdeas Grants may be funded by or in conjunction with other organisations. These grants offer opportunities to researchers whose work is particularly relevant to the priorities and research interests of the partner organisations. The amount of funding for an Ideas Grant is based on assessment of the requested budget. \nKey Dates\nApplications open: 11 March 2026\nMinimum data due date: 8 April 2026\nApplications close: 6 May 2026\nProposed peer review: June to September 2026 \nSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-ideas-grants/
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC_Ideas_Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260506T170000
DTEND;TZID=Australia/Sydney:20260506T170000
DTSTAMP:20260620T090739
CREATED:20260303T041327Z
LAST-MODIFIED:20260303T041327Z
UID:10000269-1778086800-1778086800@melanoma.org.au
SUMMARY:Cancer Council NSW Project Grant
DESCRIPTION:Applications for Cancer Council NSW and Cancer Council SA funding are aligned with the National Health and Medical Research Council’s Ideas Grants submission and review processes. \nCancer Council NSW Project Grants are: \n\nopen to research projects on any aspect of cancer\, including its causes\, mechanisms\, prevention\, treatment and care\, and the organisation and performance of cancer control services\nawarded for up to three years\nvalued up to $600\,000 over three years\nopen to all Australian cancer researchers.\n\nResearchers wishing to apply for Cancer Council NSW Project Grants must complete: \n\nNHMRC Ideas Grant application. In the Sapphire application\, please select ‘Cancer Council’ as a funding option\nSubmission of a Cancer Council NSW application through our grants portal\, which includes Lived Experience targeted questions.\n\nKey Dates\nNHMRC Ideas Grant/Cancer Council Project Grant applications open: 13 March 2026\nMinimum data due for NHMRC Ideas Grant via Sapphire: 8 April 2026\nClosing date for NHMRC Ideas Grant applications via Sapphire: 6 May 2026\nClosing date for submission of Cancer Council Project Grants application: 22 May 2026\nCancer Council advises applicants of funding outcomes: February 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/cancer-council-project-grant/
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/Cancer_Council_Project_Grant600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260522T170000
DTEND;TZID=Australia/Sydney:20260522T170000
DTSTAMP:20260620T090739
CREATED:20260331T014109Z
LAST-MODIFIED:20260331T014109Z
UID:10000271-1779469200-1779469200@melanoma.org.au
SUMMARY:ACRF Annual Research Grants
DESCRIPTION:Australian Cancer Research Foundation (ACRF) awards capital grants (between $1.5 to $5 million) for technology\, equipment and infrastructure for cancer research at Australian medical research institutes\, hospitals and universities. \nGrant applications are open to research into all types of cancer with a research focus on detection\, prevention\, and/or treatment. \nSince 1984\, ACRF has awarded $209.3 million to 93 research grants in 44 Australian cancer research institutes. \nACRF promotes collaboration amongst researchers and clinicians and encourages novel and innovative cancer research projects. All applications are competitively reviewed by the ACRF Medical Research Advisory Committee (MRAC) who recommend the best projects to the ACRF Board of Trustees for funding. \nKey Dates\nApplications close: 5:00pm\, Friday 22 May 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/acrf-annual-research-grants/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/ACRF_Annual_Grants600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260529T170000
DTEND;TZID=Australia/Sydney:20260529T170000
DTSTAMP:20260620T090739
CREATED:20260331T013722Z
LAST-MODIFIED:20260401T011603Z
UID:10000273-1780074000-1780074000@melanoma.org.au
SUMMARY:Perpetual Ramaciotti Medal for Excellence in Biomedical Research
DESCRIPTION:The Ramaciotti Medal is an annual award of $50\,000. The Medal honours an individual who has made an outstanding discovery (or discoveries) in clinical or experimental biomedical research that has had an important impact on biomedical science\, clinical science\, or the way in which healthcare is delivered. \nTo be eligible for the Ramaciotti Medal\, the greater part of the nominee’s work leading to the discovery (or discoveries) must have been conducted in Australia and they must still be actively engaged in this work. \nThe applicant must be peer nominated and the final recipient is selected based on a recommendation by the Ramaciotti Foundations Scientific Advisory Committee to Perpetual. Many past winners are highly regarded individuals in the top echelon of the biomedical research industry. \nKey Dates\nApplications close: Friday 29 May 2026\, 5pm AEST\nApplicants advised of outcome: September 2026\nRecipients announced: October 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/perpetual-ramaciotti-medal-for-excellence/
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/Ramaciotti_Medal_Perpetual-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260529T170000
DTEND;TZID=Australia/Sydney:20260529T170000
DTSTAMP:20260620T090739
CREATED:20260331T013938Z
LAST-MODIFIED:20260401T011222Z
UID:10000272-1780074000-1780074000@melanoma.org.au
SUMMARY:Perpetual Ramaciotti Health Investment Grants
DESCRIPTION:Ramaciotti Health Investment grants of up to $100\,000 are awarded to individuals in universities\, public hospitals or institutes for a contribution towards the undertaking of health or medical research with the potential path to clinical application within five years. A Health Investment grant is intended to provide enabling research support for an autonomous early career investigator who is taking\, or has recently taken\, a substantive position. \nGrants are awarded by Perpetual\, Trustee of the Foundations\, on the recommendation of a dedicated Scientific Advisory Committee. \nIn 2026 The Ramaciotti NSW Foundation will award up to six grants and The Ramaciotti Australia Foundation up to four grants. The Ramaciotti Australia Foundation supports organisations outside of NSW. \nKey Dates\nApplications close: Friday 29 May 2026\, 5pm AEST\nApplicants advised of outcome: September 2026\nRecipients announced: October 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/perpetual-ramaciotti-health-investment-grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/Ramaciotti-Health-Investment-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260530T170000
DTEND;TZID=Australia/Sydney:20260530T170000
DTSTAMP:20260620T090739
CREATED:20260331T013448Z
LAST-MODIFIED:20260331T013448Z
UID:10000274-1780160400-1780160400@melanoma.org.au
SUMMARY:The Viertel Charitable Foundation Clinical Investigator Awards
DESCRIPTION:Establishment grants for Clinical Investigators have been initiated by the Foundation in order to stimulate and encourage clinical research in Australia. In particular the grants are intended to assist new investigators to establish their research programs at the time of the difficult transition from doctoral and post-doctoral training posts to their first definitive clinical positions in an academic environment. Clinical Investigators are awarded a once only grant of $90\,000. \nEligible applicants will be medical graduates or graduates of other clinical disciplines who have completed both their clinical and research training which will normally be at doctoral level and are commencing their first definitive clinical position\, or have been in such a post for no more than 36 months on 1 May of the year of application. \nApplicants should be actively engaged in clinical work and pursuing health and medical research in a university clinical department\, a teaching hospital\, a clinical research unit of a research institute or in an academic general practice setting. The applications will be judged predominantly on the quality of the applicant’s track record and career achievements to date. The quality of a brief research proposal will also be taken into account. \nKey Dates\nApplications open: 6 April 2026\nApplications close: 30 May 2026 \nThe Guidelines will be available here when the round opens. \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/the-viertel-foundation-investigator-awards/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/The-Viertel-Clinical-Investigator-Awards-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR